You have 9 free searches left this month | for more free features.

City

Wenzhou (1)

Condition

Cataract (1)

IOL (1)

PEComa, Malignant (1)

TSC1 (1)

TSC2 (1)

mTOR Pathway Abberation (1)

Overall Status

Approved for marketing (1)

Enrolling by invitation (1)

Phase

Sponsor

Aadi Bioscience, Inc. (1)

Wenzhou Medical University (1)

Collaborator

Intervention

abi-009 (1)

zxr00 (1)

Study Documents

Intervention Type

device (1)

drug (1)

Funder Type

Industry (1)

Other (1)

Study Type

Expanded Access (1)

Observational (1)

abberation

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

PEComa, Malignant, TSC1, TSC2 Trial (ABI-009)

Approved for marketing

PEComa, Malignant
+3 more

ABI-009

(no location specified)

Mar 2, 2022

Visual Performance of Multifocal Intraocular Lenses

Enrolling by invitation

IOL
Cataract

ZXR00

Wenzhou, Zhejiang, China

Ophthalmology and Optometry Hospital

May 30, 2021